Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Decitabine Versus Supportive Care in Adults With Advanced-stage MDS

ClinicalTrials.gov ID: NCT00043381

Public ClinicalTrials.gov record NCT00043381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 7:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Phase III Trial of Decitabine (5-aza-2'Deoxycytidine) Versus Supportive Care in Adults With Advanced-stage Myelodysplastic Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the safety and efficacy profiles of decitabine to those of supportive care in adults with advanced-stage myelodysplastic syndrome (MDS)

Study identification

NCT ID
NCT00043381
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astex Pharmaceuticals, Inc.
Industry
Enrollment
160 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2001 (Type not available)
Primary completion
Nov 2002 (Actual)
Completion
Apr 2003 (Actual)
Last update posted
Aug 2, 2024

2001 – 2003

United States locations

U.S. sites
24
U.S. states
10
U.S. cities
20
Facility City State ZIP Site status
Alta Bates Comprehensive Cancer Center Berkeley California — —
City of Hope National Medical Center Duarte California — —
Scripps Clinic Escondido California — —
Loma Linda Univ. Cancer Center Loma Linda California — —
Univ. California San Francisco Medical School San Francisco California — —
University of Florida Gainesville Florida — —
H. Lee Moffitt Cancer Center Tampa Florida — —
James A. Haley Veteran's Hospital Tampa Florida — —
Rush Medical Center Chicago Illinois — —
University of Illinois at Chicago Chicago Illinois — —
Dana Farber Cancer Institute Boston Massachusetts — —
New England Medical Center Hospital Boston Massachusetts — —
University of Massachusetts Medical School Worcester Massachusetts — —
VA Medical Center Minneapolis Minnesota — —
Washington Univ. School of Medicine St Louis Missouri — —
Roswell Park Cancer Institute Buffalo New York — —
Memorial Sloan Kettering Cancer Center New York New York — —
Mount Sinai Medical Center New York New York — —
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina — —
Duke University Medical Center Durham North Carolina — —
The Memphis Cancer Center Memphis Tennessee — —
SW Regional Cancer Center (dba Central Texas Oncology Associates) Austin Texas — —
Texas Oncology Dallas Texas — —
MD Anderson Cancer Center Houston Texas — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00043381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2024 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00043381 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →